martino introna
martino introna
Qualified Person, Centro di Terapia Cellulare "G. Lanzani" ASST Papa Giovanni XXIII Bergamo Italy
Email verificata su
Citata da
Citata da
Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis
J Golay, L Zaffaroni, T Vaccari, M Lazzari, GM Borleri, S Bernasconi, ...
Blood, The Journal of the American Society of Hematology 95 (12), 3900-3908, 2000
Complement activation determines the therapeutic activity of rituximab in vivo
N Di Gaetano, E Cittera, R Nota, A Vecchi, V Grieco, E Scanziani, M Botto, ...
The Journal of Immunology 171 (3), 1581-1587, 2003
Cytokine regulation of endothelial cell function: from molecular level to the bedside
A Mantovani, F Bussolino, M Introna
Immunology today 18 (5), 231-235, 1997
CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59
J Golay, M Lazzari, V Facchinetti, S Bernasconi, G Borleri, T Barbui, ...
Blood 98 (12), 3383-3389, 2001
PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans
G Peri, M Introna, D Corradi, G Iacuitti, S Signorini, F Avanzini, F Pizzetti, ...
Circulation 102 (6), 636-641, 2000
Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3 similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component
B Bottazzi, V Vouret-Craviari, A Bastone, L De Gioia, C Matteucci, G Peri, ...
Journal of Biological Chemistry 272 (52), 32817-32823, 1997
Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program
M Chieppa, G Bianchi, A Doni, A Del Prete, M Sironi, G Laskarin, P Monti, ...
The Journal of Immunology 171 (9), 4552-4560, 2003
Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice
M Morigi, M Introna, B Imberti, D Corna, M Abbate, C Rota, D Rottoli, ...
Stem cells 26 (8), 2075-2082, 2008
Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin
F Breviario, L Caveda, M Corada, I Martin-Padura, P Navarro, J Golay, ...
Arteriosclerosis, thrombosis, and vascular biology 15 (8), 1229-1239, 1995
The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity
F Tedesco, M Pausa, E Nardon, M Introna, A Mantovani, A Dobrina
The Journal of experimental medicine 185 (9), 1619-1628, 1997
Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes
VV Alles, B Bottazzi, G Peri, J Golay, M Introna, A Mantovani
Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells
S Tomasoni, L Longaretti, C Rota, M Morigi, S Conti, E Gotti, C Capelli, ...
Stem cells and development 22 (5), 772-780, 2013
Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility
N Perico, F Casiraghi, M Introna, E Gotti, M Todeschini, RA Cavinato, ...
Clinical Journal of the American Society of Nephrology 6 (2), 412-422, 2011
Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone
N Di Gaetano, Y Xiao, E Erba, R Bassan, A Rambaldi, J Golay, M Introna
British journal of haematology 114 (4), 800-809, 2001
Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites
M Introna, VV Alles, M Castellano, G Picardi, L De Gioia, B Bottazzai, ...
M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro
M Leidi, E Gotti, L Bologna, E Miranda, M Rimoldi, A Sica, M Roncalli, ...
The Journal of Immunology 182 (7), 4415-4422, 2009
Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity
A Pievani, G Borleri, D Pende, L Moretta, A Rambaldi, J Golay, M Introna
Blood, The Journal of the American Society of Hematology 118 (12), 3301-3310, 2011
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study
M Introna, G Borleri, E Conti, M Franceschetti, AM Barbui, R Broady, ...
haematologica 92 (7), 952-959, 2007
Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA)
MM Luchetti, G Piccinini, A Mantovani, G Peri, C Matteucci, G Pomponio, ...
Clinical & Experimental Immunology 119 (1), 196-202, 2000
Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab
J Golay, F Da Roit, L Bologna, C Ferrara, JH Leusen, A Rambaldi, C Klein, ...
Blood 122 (20), 3482-3491, 2013
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20